Trial Profile
Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Doses of 40 mg Telmisartan/5 mg Amlodipine and 80 mg Telmisartan/5 mg Amlodipine (Free Dose Combination) in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Jul 2014
Price :
$35
*
At a glance
- Drugs Amlodipine (Primary) ; Telmisartan (Primary)
- Indications Essential hypertension
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim
- 22 Jul 2014 New trial record